Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 12;145(15):1123–1139. doi: 10.1161/CIRCULATIONAHA.121.056817

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 American Heart Association, Inc.

This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

PMC Copyright notice

Figure 4. — Kaplan

-Meier estimates of 120-day overall mortality and mortality or need for temporary mechanical circulatory support (t-MCS) in patients with COVID-19–associated acute myocarditis (AM). A, Mortality in the whole study population with COVID-19 am and (B) Mortality in patients with COVID-19 am with (w/) pneumonia on the basis of radiographic examinations compared with patients with COVID-19 am without (w/o) pneumonia. Three noncardiac deaths occurred: 2 deaths caused by septic shock and 1 caused by hemorrhagic stroke. C, Mortality or need for t-MCS in the whole study population with COVID-19 am and (D) Mortality or need for t-MCS in patients with COVID-19 am with pneumonia compared with patients with COVID-19 am without pneumonia. Among 10 patients who received a t-MCS, 2 died on support (1 septic shock and 1 hemorrhagic stroke). HR indicates hazard ratio. *Indicates statistically significant with P<0.05.